Dataset: Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.

The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050. Cultured A549 human lung cancer cells were treated with sapphyrin PCI-2050 or actinomycin D.

Species:

human

Samples:

12

Source:

E-GEOD-6400

PubMed:

17233922

Updated:

Dec.12, 2014

Registered:

Sep.21, 2014